Please fill in the form and we will promptly contact you.
GENERAL INQUIRIES:
Fields marked with an * are required
To contact us, please fill in the form and we will be happy to contact you.
OUR TEAM
SarcoMed USA is comprised of experienced biotech entrepreneurs with strong drug development expertise, including Sarcoidosis clinical advisors. The company has initiated a human open label study using Generium’s biosimilar DNase1, in a Proof‐of‐Concept study in Kazakhstan.